The earnings call presented both positive and negative aspects. Highlights included revenue growth in certain segments and improved margins due to strategic repositioning and cost savings. However, these were tempered by significant sales declines, restructuring charges, and ongoing challenges in Performance Chemicals. Overall, the sentiment is balanced, with strategic initiatives showing progress but also highlighting current financial pressures.
Company Guidance
In the Ingevity Q3 2024 earnings call, the company provided guidance for the remainder of the year, anticipating revenues at the lower end of their previously projected range of $1.4 billion to $1.5 billion, with adjusted EBITDA expected between $350 million and $360 million. This outlook is influenced by several factors, including seasonal low demand in their Road Technologies segment and ongoing high-cost crude tall oil (CTO) inventory in Performance Chemicals. Despite these challenges, Ingevity aims to improve its financial performance through strategic repositioning and cost-saving measures, such as the closure of their Crossett facility, which is expected to yield $20 million to $25 million in savings. The company is also focusing on reducing leverage and enhancing free cash flow, with a target to achieve $400 million in EBITDA by 2025 and leverage of around 3x by year-end 2025.
Performance Materials Sales Growth
The segment delivered solid sales growth of 3% to $151.1 million, with an EBITDA margin of 53.3%, benefiting from lower input costs and improved operational efficiency.
APT Revenue Increase
Advanced Polymer Technologies (APT) revenue increased by 14% to $48.8 million due to improved volumes, particularly in China, indicating potential market demand recovery.
Gross Margin Improvement
Adjusted gross margin improved by 610 basis points, driven by repositioning actions in Performance Chemicals and cost savings of $14 million.
Free Cash Flow Generation
Generated free cash flow of $28.5 million in Q3, despite significant restructuring and contract termination payments.
---
Ingevity (NGVT) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NGVT Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2024
$35.32
$41.65
+17.92%
Jul 31, 2024
$45.89
$42.64
-7.08%
May 01, 2024
$51.89
$54.80
+5.61%
Feb 21, 2024
$44.97
$47.40
+5.40%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Ingevity (NGVT) report earnings?
Ingevity (NGVT) is schdueled to report earning on Feb 18, 2025, TBA Not Confirmed.
What is Ingevity (NGVT) earnings time?
Ingevity (NGVT) earnings time is at Feb 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.